Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis
- PMID: 15693088
Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis
Abstract
Objective: To evaluate peripheral blood mononuclear cells (PBMC) expressing natural killer (NK) cell surface markers (CD16 and CD56, in both CD3- and CD3+ cells) and g/d T cell receptors (TCR) involved in non-MHC-restricted cytotoxicity, assessing their possible relationship with clinical and laboratory variables in patients with systemic sclerosis (SSc).
Methods: We submitted 50 patients with SSc to detailed clinical and laboratory assessment, and also performed PBMC subset analyses by direct dual immunofluorescence and flow cytometry.
Results: No statistically significant differences were found in the percentages or the absolute numbers of total lymphocytes, of B cells, and of CD4+ T cells. The absolute number of CD8+ cells was lower (p < 0.03), while HLA-DR+ elements were higher in frequency (p < 0.03) in SSc patients than in healthy controls. SSc patients had lower values (both percentage and absolute number) of NK-T cells (p < 0.01 and p < 0.003, respectively) and of T cells expressing g/d TCR (p < 0.01 and p < 0.005, respectively); whereas NK cells were marginally but not significantly decreased. The absolute number of NK-T cells showed an inverse correlation to erythrocyte sedimentation rate values (p < 0.03; rs = -0.306), percentage of g-globulins (p < 0.01; rs = -0.353), and serum concentrations of IgG (p < 0.02; rs = -0.334).
Conclusion: Impairment of NK-T cells and of T cells expressing g/d TCR may lead to downregulation of normal immune response, and seems to be important for immunological and inflammatory aspects of SSc.
Similar articles
-
Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.Cytometry B Clin Cytom. 2009 May;76(3):213-7. doi: 10.1002/cyto.b.20455. Cytometry B Clin Cytom. 2009. PMID: 18803280
-
Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.Mediators Inflamm. 1999;8(6):305-12. doi: 10.1080/09629359990315. Mediators Inflamm. 1999. PMID: 10815619 Free PMC article.
-
Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.Arthritis Rheum. 1998 Feb;41(2):327-34. doi: 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S. Arthritis Rheum. 1998. PMID: 9485091 Review.
-
Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?Lupus. 2000;9(5):333-7. doi: 10.1191/096120300678828460. Lupus. 2000. PMID: 10878724
-
Porcine T lymphocytes and NK cells--an update.Dev Comp Immunol. 2009 Mar;33(3):310-20. doi: 10.1016/j.dci.2008.06.003. Epub 2008 Jul 2. Dev Comp Immunol. 2009. PMID: 18601948 Review.
Cited by
-
Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.Clin Exp Immunol. 2006 Dec;146(3):371-80. doi: 10.1111/j.1365-2249.2006.03216.x. Clin Exp Immunol. 2006. PMID: 17100755 Free PMC article.
-
Selected Aspects in the Pathogenesis of Autoimmune Diseases.Mediators Inflamm. 2015;2015:351732. doi: 10.1155/2015/351732. Epub 2015 Aug 2. Mediators Inflamm. 2015. PMID: 26300591 Free PMC article. Review.
-
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.Arthritis Res Ther. 2012 Apr 24;14(2):R85. doi: 10.1186/ar3809. Arthritis Res Ther. 2012. PMID: 22531499 Free PMC article.
-
Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.Front Immunol. 2018 Jul 18;9:1665. doi: 10.3389/fimmu.2018.01665. eCollection 2018. Front Immunol. 2018. PMID: 30072999 Free PMC article.
-
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication.Rheumatol Int. 2022 Aug;42(8):1373-1381. doi: 10.1007/s00296-021-05034-8. Epub 2021 Oct 25. Rheumatol Int. 2022. PMID: 34694439 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials